English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Jul 15, 2025

Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating

Patient Daily | Jul 15, 2025

Scottsdale Sinus & Allergy Center garners 500+ Google reviews with a 4.9-star rating

+ Pharmaceuticals
Patient Daily | Jul 15, 2025

Baylor College adds two new trustees with extensive leadership experience

+ Pharmaceuticals
Patient Daily | Jul 15, 2025

American Lung Association advises parents on preparing asthmatic children for school

+ Pharmaceuticals
Patient Daily | Jul 14, 2025

Ut System Regents name Melina R. Kibbe sole finalist for UtHealth Houston presidency

Patient Daily | Jul 11, 2025

Physician assistant on headaches and sinusitis: ‘Sinus headaches are known to trigger your migraines’

+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'

+ Pharmaceuticals
Patient Daily | Jul 10, 2025

American Lung Association hosts backpack drive for students on August 2

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 239
  • 240
  • 241
  • 242
  • 243
  • 244
  • 245
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily